 |
-
Investing Long-Term Money for Long-Term Returns: John Thurston Beaty Jr., Beaty Haynes & Assoc.
-
Investing in Healthcare Stocks: Derek M. Taner, AIM Investments
-
Investing in Quality Growth Companies: Grace Keeney Fey, Frontier Capital Mgmt.
-
Investing in Mid-Cap Stocks: K. William Nolin, Principal Global Investors
-
Global Economics: An Overview: Christopher Probyn, State Street Global Advisors
-
Bel Air Investment Strategies: James Stephenson, Bel Air Investment Advisors
Topics covered: Rapid dividend growth
- Technology trends
- Federal Medicare program
- Volatility impact
- Investment risk control
- New product development
- Tax efficiency
- Currency problems
- Patent issues
- Environmental standards
Companies covered: MedImmune (MEDI), Zimmer (ZMH), Wright Medical (WMGI), Medtronic (MDT), DENTSPLY (XRAY), Lifeline Systems (LIFE), Coventry Health Care (CVH), Questar (STR), Weatherford International (WFT), Fluor Corporation (FLR), Suncor (SU), Unocal (UCL), BHP Billiton (BHP), Bank of America (BAC), Alliance Capital (AC), Dell (DELL), Microsoft (MSFT), VeriSign (VRSN), NeuStar (NSR), Rockwell Collins (COL), Pharmaceutical Product Development (PPDI), Medicis Pharmaceutical (MRX), Roche Holding (RHHVF), XTO Energy (XTO), FedEx (FDX), Exxon Mobil (XOM), Biogen Idec (BIIB), Gentex (GNTX), Cintas (CTAS), CarMax (KMX), Arbitron (ARB), Citigroup (C), Medtronic (MDT), QUALCOMM (QCOM), CVS (CVS) and Clear Channel Communications (CCU).
This Issue
costs $175 - and is non-returnable.
The Wall Street Transcript
does not endorse the views of any interviewee nor does it make stock recommendations.
|
 |

Investors and Industry Execs.
The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.
TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best.
Money manager interviews provide the view from the buy-side.
CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.
Subscribe to a unique research tool for investors and industry executives. Call
(212) 952 7433 or click here.
Sincerely,
Andrew Pickup
Publisher
|
|
 |